FRAXA's mission is to find effective treatments and a cure for all children and adults with Fragile X, by directly funding the most promising research. As the pace of Fragile X research accelerates, the prospects of finding effective treatments and a cure for Fragile X and autism continue to improve. FRAXA-funded researchers at universities around the world are leading the way.
2016 Research Grants coming April 2016
The applications are in, and now they are under review by members of FRAXA’s Scientific Advisory Board and other specialists. We expect to fund $1 million in new grants this spring.
FRAXA has Funded over $25 Million in New Biomedical Research
Each February 1, we receive 30-60 applications for postdoctoral fellowships and program grants. This is cutting-edge work! Browse funded research here.
FRAXA's research portfolio spans the spectrum of translational, pre-clinical, and clinical research -- all coordinated to make the most of each dollar. We maintain a diversified approach, developing several treatment strategies in parallel, since success is never certain when developing a single drug.
“Fragile X is poised to become a triumph for translational research and the design of rational therapeutics for brain disease.”
- Dr. Justin Fallon, FRAXA Scientific Advisor